In this issue:
- Novel individualised aflibercept treatment protocol for branch retinal vein inclusion with macular oedema
- Incidence & mortality of RAO
- Aflibercept monotherapy vs. bevacizumab-first for diabetic macular oedema
- Cost-effectiveness of aflibercept monotherapy vs. bevacizumab-first for diabetic macular oedema
- Dexamethasone intravitreal implant in treatment-naïve diabetic macular oedema
- Time to resolution of diabetic macular oedema after aflibercept injection vs. laser
- Prostaglandin analogue use & cystoid macular oedema following cataract surgery
- Transcranial direct current stimulation for hallucinations in Charles Bonnet Syndrome
- Fibrosis in neovascular age-related macular degeneration
- Ganglion cell complex thinning & central visual field loss
Please login below to download this issue (PDF)